-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Olema Pharmaceuticals, Raises Price Target to $60

Benzinga·12/12/2025 13:04:16
語音播報
Citigroup analyst Yigal Nochomovitz maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and raises the price target from $21 to $60.